Securities Code: 300759
Securities Abbreviation: Kanglong Chemical
Announcement Number: 2026-012
Kanglong Chemical (Beijing) New Drug Technology Co., Ltd. Announcement on the Use of Part of Own Funds to Purchase Wealth Management Products
Important Content Reminder:
- Investment Type: The company intends to use part of its idle funds and funds raised from the H-share placement in January 2026 (collectively referred to as "idle own funds") to purchase low to medium-risk wealth management products with high safety and liquidity, including principal-protected cash management products, while ensuring the company's daily liquidity needs and controlling financial risks.
- Investment Amount: The company plans to use no more than RMB 5 billion of idle own funds, which can be recycled during the investment period.
- Special Risk Reminder: Although low to medium-risk wealth management products carry lower risks, the financial market is significantly influenced by macroeconomic factors, and market fluctuations may affect this investment. Investors are advised to be aware of investment risks.
The company held the 19th meeting of the 3rd Board of Directors on March 30, 2026, where the proposal on the use of part of own funds to purchase wealth management products was approved. To improve capital efficiency and reasonably utilize idle own funds without affecting the normal operations of the company and its subsidiaries, part of the idle own funds will be used to purchase low to medium-risk wealth management products with high safety and liquidity. The specific situation is announced as follows: